BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37810555)

  • 1. Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9787264. PubMed ID: 37810555
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chen Z; Cui S; Dai Y; Lu C; Zhang H; Zhao W; Yan H; Zhang Y
    Oxid Med Cell Longev; 2022; 2022():7595230. PubMed ID: 36193074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer.
    Oncology JO
    J Oncol; 2023; 2023():9807856. PubMed ID: 37946722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9801756. PubMed ID: 37593684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma.
    Engineering JOH
    J Healthc Eng; 2023; 2023():9820907. PubMed ID: 36714411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9837208. PubMed ID: 37476733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: A Potential Prognostic Biomarker for Glioma: Aldo-Keto Reductase Family 1 Member B1.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9798269. PubMed ID: 37829854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Pan-Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9790580. PubMed ID: 38125110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9761231. PubMed ID: 37388089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9856509. PubMed ID: 37810558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: PCBP2 Reduced Oxidative Stress-Induced Apoptosis in Glioma through cGAS/STING Pathway by METTL3-Mediated m6A Modification.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9813487. PubMed ID: 37810561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Identification of
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9831674. PubMed ID: 38189011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9838096. PubMed ID: 38094385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: High SIRPA Expression Predicts Poor Prognosis and Correlates with Immune Infiltrates in Patients with Esophageal Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9758202. PubMed ID: 37860319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.
    International BR
    Biomed Res Int; 2024; 2024():9824604. PubMed ID: 38549965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes.
    International BR
    Biomed Res Int; 2024; 2024():9854370. PubMed ID: 38550201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Inflammation and Oxidative Stress Role of S100A12 as a Potential Diagnostic and Therapeutic Biomarker in Acute Myocardial Infarction.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9789872. PubMed ID: 38189005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment.
    Oncology JO
    J Oncol; 2023; 2023():9839681. PubMed ID: 37476552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Molecular Typing Based on Oxidative Stress Genes and Establishment of Prognostic Characteristics of 7 Genes in Lung Adenocarcinoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9841973. PubMed ID: 37593682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.